Rheumatoid Arthritis

Your daily dose of clinical news you may have missed.

Patients with rheumatoid arthritis and fibromyalgia were at the greatest risk of transitioning to long-term opioid use 1 year after a first prescription, a new study found.

A recent meta-analysis assessed comparative clinical efficacy of NSAIDs and COX-2 inhibitors. Try these 7 questions on the findings - does your clinical experience match?

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about? Click through to find out. 

Primary care physicians may contribute to improved outcomes by recognizing the signs and symptoms early on. Part 2 of a Special Report.

For key facts and figures about musculoskeletal disorders, perhaps a surprise as the fourth leading diagnostic category in primary care, see the pages that follow.

What brings patients to your office-and not the specialty office down the street? Insights in this slideshow.

A new era in hepatitis C treatment began in May 2011, with approval of telaprevir and boceprevir. They are effective only for some patients, but new and better options are well on their way to the clinic.

Much like HIV/AIDS, RA is associated with a higher risk of cardiovascular disease and consequent death. How might inflammation add to the risk?

Joint deformity is far from the only concern in rheumatoid arthritis. The condition is associated with a variety of comorbidities and adverse events related to the medications used to prevent or treat symptoms, as these photos attest.